Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Issue 4 (29th April 2021)

• Record Type: Journal Article
• Authors: Sonnweber, Thomas; Sahanic, Sabina; Pizzini, Alex; Luger, Anna; Schwabl, Christoph; Sonnweber, Bettina; Kurz, Katharina; Koppelstätter, Sabine; Haschka, David; Petzer, Verena; Boehm, Anna; Aichner, Magdalena; Tymoszuk, Piotr; Lener, Daniela; Theurl, Markus; Lorsbach-Köhler, Almut; Tancevski, Amra; Schapfl, Anna; Schaber, Marc; Hilbe, Richard; Nairz, Manfred; Puchner, Bernhard; Hüttenberger, Doris; Tschurtschenthaler, Christoph; Aßhoff, Malte; Peer, Andreas; Hartig, Frank; Bellmann, Romuald; Joannidis, Michael; Gollmann-Tepeköylü, Can; Holfeld, Johannes; Feuchtner, Gudrun; Egger, Alexander; Hoermann, Gregor; Schroll, Andrea; Fritsche, Gernot; Wildner, Sophie; Bellmann-Weiler, Rosa; Kirchmair, Rudolf; Helbok, Raimund; Prosch, Helmut; Rieder, Dietmar; Trajanoski, Zlatko; Kronenberg, Florian; Wöll, Ewald; Weiss, Günter; Widmann, Gerlig; Löffler-Ragg, Judith; Tancevski, Ivan;
• Is Part Of: European respiratory journal. Volume 57:Issue 4(2021)
• Publication Date: 2021-04-29
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.03481-2020
• Languages: English
• ISSNs: 0903-1936

Abstract

Background: After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of survivors exhibited persisting structural pulmonary abnormalities. The long-term pulmonary sequelae of coronavirus disease 2019 (COVID-19) are yet unknown, and comprehensive clinical follow-up data are lacking. Methods: In this prospective, multicentre, observational study, we systematically evaluated the cardiopulmonary damage in subjects recovering from COVID-19 at 60 and 100 days after confirmed diagnosis. We conducted a detailed questionnaire, clinical examination, laboratory testing, lung function analysis, echocardiography and thoracic low-dose computed tomography (CT). Results: Data from 145 COVID-19 patients were evaluated, and 41% of all subjects exhibited persistent symptoms 100 days after COVID-19 onset, with dyspnoea being most frequent (36%). Accordingly, patients still displayed an impaired lung function, with a reduced diffusing capacity in 21% of the cohort being the most prominent finding. Cardiac impairment, including a reduced left ventricular function or signs of pulmonary hypertension, was only present in a minority of subjects. CT scans unveiled persisting lung pathologies in 63% of patients, mainly consisting of bilateral ground-glass opacities and/or reticulation in the lower lung lobes, without radiological signs of pulmonary fibrosis. Sequential follow-up evaluations at 60 and 100 days after COVID-19 onset demonstrated a vast improvement of symptoms and CT abnormalities over time. Conclusion: A relevant percentage of post-COVID-19 patients presented with persisting symptoms and lung function impairment along with radiological pulmonary abnormalities >100 days after the diagnosis of COVID-19. However, our results indicate a significant improvement in symptoms and cardiopulmonary status over time. 100 days after COVID-19 onset, a high portion of patients exhibit persisting symptoms and cardiopulmonary impairment. Still, a marked improvement of symptoms, pulmonary function and CT pathologies was found at follow-up. https://bit.ly/35YP13g